Brief: Rua Bioscience Gets Approval From New Zealand Medicinal Cannabis Agency
04/08/2026 02:25
BRIEF-Rua Bioscience Gets Approval From New Zealand Medicinal Cannabis Agency Aug 4 (Reuters) - Rua Bioscience Ltd RUA.NZ:
GOT APPROVAL FROM NEW ZEALAND MEDICINAL CANNABIS AGENCY FOR FIVE NEW MEDICINAL CANNABIS PRODUCTS
EXPECTS SALES IN NEW ZEALAND TO COMMENCE IN COMING MONTHS, AS PRODUCT BECOMES AVAILABLE
Further company coverage: RUA.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth